Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (2): 200-209.doi: 10.3736/jcim20120211
• Original Experimental Research • Previous Articles Next Articles
Zhou Xian-mei1(
),Zhao Yang1,He Cui-cui2,Li Jian-xin2
| [1] |
Han MK, Swigris J, Liu L, Bartholmai B, Murray S, Giardino N, Thompson B, Frederick M, Li D, Schwarz M, Limper A, Flaherty K, Martinez FJ . Gender influences Health-Related Quality of Life in IPF. Respir Med. 2010; 104(5):724-730.
doi: 10.1016/j.rmed.2009.11.019 pmid: 2862780 |
| [2] |
Agarwal R, Jindal SK . Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur J Intern Med. 2008; 19(4):227-235.
doi: 10.1016/j.ejim.2007.04.024 pmid: 18471669 |
| [3] |
Bringardner BD, Baran CP, Eubank TD, Marsh CB . The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal. 2008; 10(2):287-301.
doi: 10.1089/ars.2007.1897 |
| [4] |
Harari S, Caminati A . IPF: new insight on pathogenesis and treatment. Allergy. 2010 ; 65(5) : 537-553.
doi: 10.1111/j.1398-9995.2009.02305.x pmid: 20121758 |
| [5] |
Parra ER, Kairalla RA , Ribeiro de Carvalho CR, Eher E, Capelozzi VL. Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration. 2007; 74(2):159-169.
doi: 10.1159/000097133 pmid: 17108669 |
| [6] |
Dempsey DJ . Clinical review: Idiopathic pulmonary fibrosis —past, present and future. Respir Med. 2006; 100(11):1871-1885.
doi: 10.1016/j.rmed.2006.08.017 pmid: 16987645 |
| [7] |
Gomer RH, Lupher ML Jr . Investigational approaches to therapies for idiopathic pulmonary fibrosis. Expert Opin Investig Drugs. 2010; 19(6):737-745.
doi: 10.1517/13543784.2010.484018 pmid: 20443753 |
| [8] |
Yang J, Cui Y, Kolb M . How useful is traditional herbal medicine for pulmonary fibrosis? Respirology. 2009; 14(8) : 1082-1091.
doi: 10.1111/j.1440-1843.2009.01644.x pmid: 19909458 |
| [9] |
Jiang HD, Guan HS . MS80, a novel sulfated oligosaccharide, inhibits pulmonary fibrosis by targeting TGF- betal both in vitro and in vivo. Acta Pharmacol Sin. 2009; 30(7) : 973-979.
doi: 10.1038/aps.2009.86 |
| [10] |
Zhou XM, Zhang GC, Li JX, Hou J . Inhibitory effects of citrus extracts on the experimental pulmonary fibrosis. J Ethnopharmacol. 2007 ; 111(2) : 255-264.
doi: 10.1016/j.jep.2006.11.029 pmid: 17188826 |
| [11] |
Zhou XM, Huang MM, He CC, Li JX . Inhibitory effects of citrus extracts on the experimental pulmonary fibrosis. J Ethnopharmacol. 2009; 126(1):143-148.
doi: 10.1016/j.jep.2009.07.025 pmid: 19643175 |
| [12] |
Peterson JJ, Dwyer JT, Beecher GR, Bhagwat SA, Gebhardt SE, Haytowitz DB, Holden JM . Flavanones in oranges, tangerines (mandarins), tangors, and tangelos: a compilation and review of the data from the analytical literature. J Food Compost Anal. 2006; 19(Suppl):S66-S73.
doi: 10.1016/j.jfca.2005.12.006 |
| [13] |
Yu L, Li X, Liu S, Xu G, Liang Y . Comparative analysis of volatile constituents in Citrus reticulata Blanco using GC-MS and alternative moving window factor analysis. J Sep Sci. 2009; 32(20):3457-3465.
doi: 10.1002/jssc.v32:20 |
| [14] |
Xu P . Comparison of pharmacological effects in water extract and essential oil of Citrus reticulata. Jiangxi Zhong Yi Xue Yuan Xue Bao. 1998; 10(4) : 172-173. Chinese.
doi: 10.3969/j.issn.1005-9431.1998.04.022 |
|
徐彭 . 陈皮水提物和陈皮挥发油的药理作用比较.江西中医学院学报. 1998; 10(4):172-173.
doi: 10.3969/j.issn.1005-9431.1998.04.022 |
|
| [15] | China Pharmacopoeia Commission. Pharmacopoeia of the Peopled Republic of China (part one). 2005 ed. Beijing: Chemical Industry Press. 2005: 53. Chinese. |
| 国家药典委员会. 中华人民共和国药典(一部).2005 年版.北京: 化学工业出版社. 2005: 53. | |
| [16] |
Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW, Crystal RG . Bleomycin-induced interstitial pulmonary disease in the nude, a thymic mouse. Am Rev Respir Dis. 1979; 120(4) : 893-839.
doi: 10.1164/arrd.1979.120.4.893 pmid: 92208 |
| [17] |
Ohkawa H, Ohishi N, Yagi K . Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2) : 351-358.
doi: 10.1016/0003-2697(79)90738-3 |
| [18] |
Oyanagui Y . Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem. 1984; 142(2):290-296.
doi: 10.1016/0003-2697(84)90467-6 |
| [19] |
Kohyama T, Yamauchi Y, Takizawa H, Itakura S, Kamitani S, Kato J, Nagase T . Clarithromycin inhibits fibroblast migration. Respir Med. 2008; 102(12):1769-1776.
doi: 10.1016/j.rmed.2008.06.020 |
| [20] |
Chua F, Gauldie J, Laurent GJ . Pulmonary fibrosis: searching for model answers. Am[J] Respir Cell Mol Biol. 2005; 33(1):9-13.
doi: 10.1165/rcmb.2005-0062TR |
| [21] |
Moeller A, Ask K, Warburton D, Gauldie J, Kolb M . The bleomycin animal model : a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008; 40(3) : 362-382.
doi: 10.1016/j.biocel.2007.08.011 |
| [22] |
Gharaee-Kermani M, Ullenbruch M, Phan SH . Animal models of pulmonary fibrosis. Methods Mol Med. 2005; 117:251-259.
doi: 10.1385/1-59259-940-0:251 pmid: 16118457 |
| [23] |
Gao F, Kinnula VL, Myllarniemi M, Oury TD . Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal. 2008; 10(2):343-354.
doi: 10.1089/ars.2007.1908 pmid: 2290736 |
| [24] |
Boyaci H, Maral H, Turan G, Basyiğit I, Dillioğlugil MÖ, Yildiz F, Tugay M, Pala A, Ercin C . Effects of erdosteine on bleomycin-induced lung fibrosis in rats. Mol Cell Biochem. 2006; 281(1-2):129-137.
doi: 10.1007/s11010-006-0640-3 pmid: 16328965 |
| [25] |
Cairns JA, Walls AF . Mast cell tryptase stimulates the synjournal of type I collagen in human lung fibroblasts. J Clin Invest. 1997; 99(6):1313-1321.
doi: 10.1172/JCI119290 |
| [26] | Kothapalli D, Frazier KS, Welply A, Segarini PR, Grotendorst GR . Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ. 1997 ; 8(1):61-68. |
| [27] |
Scotton CJ, Chambers RC . Molecular targets in pulmonary fibrosis : the myofibroblast in focus. Chest. 2007 ; 132(4):1311-1321.
doi: 10.1378/chest.06-2568 |